Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Still Awaiting Consolidated Results

<< Previous

Bullboard Posts

Next >>

Comment by GoldenDilemmaon Mar 15, 2016 11:36am

67 Views

Post# 24659892

RE:Still Awaiting Consolidated Results

Nobody cares about Tribute. They want yosprala approval. Since post Hilary, the market has continued to price POZN/TRX (now Aralez) with the tone of "show me what you're made of"

and, with projections of Q4 approval there isn't gonna be a whole lot to cause an upswing when all eggs are in the Yosprala basket.

too much hope and optomism on this board. I'm underwater at 1.38 (TRX price) and the best to do is ignore entirely till anticipated approval.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market